RxDoctor Payments Data

Bernie Parrish, MD

Family Medicine · Springfield, MONPI 1629178108

Payments from drug & device makers

$1,787in general payments, 2019–2025

Across 139 payments — averaging $12.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$457
  • Pfizer$309
  • Johnson & Johnson$234
  • Boehringer Ingelheim$207
  • E.r. Squibb & Sons, L.L.C.$147
  • Amgen$141
  • plus $291 from 7 others

What the payments were for

  • Food & beverage$1,77499%
  • Education$121%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,787 in reported general payments places this provider in the 70th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$70,939
Medicare patients
196
Services billed
1,404

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban170$160,817
XareltoRivaroxaban38$40,980
FarxigaDapagliflozin Propanediol25$24,984
JanuviaSitagliptin Phosphate27$23,352
JardianceEmpagliflozin11$9,996
ArexvyRsvpref3 Antigen/As01e/Pf31$8,778
Lantus SolostarInsulin Glargine,hum.Rec.Anlog42$5,547
Gabapentin183$4,292
Pantoprazole Sodium353$3,774
Metoprolol Succinate335$3,396
Duloxetine Hcl48$3,142
Albuterol Sulfate HfaAlbuterol Sulfate99$2,734
Rosuvastatin Calcium266$2,698
Amlodipine Besylate570$2,350
Losartan Potassium371$2,312

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$309$160,817170 claims
Johnson & JohnsonXarelto$234$40,98038 claims
AstraZenecaFarxiga$457$24,98425 claims
Boehringer IngelheimJardiance$207$9,99611 claims
GSKArexvy$24$8,77831 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in Springfield

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →